Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

CRISPR biotech Intellia strikes licensing deal with Regeneron, readies IPO
BioPharma Dive
Mon, 04/11/16 - 11:22 pm
Tags:
CRISPR, Intellia Therapeutics, Regeneron, IPOs
2 Biotech Companies That Could Profit if Their Skin Treatments Are Successful
TheStreet.com
Tue, 04/5/16 - 10:06 pm
Tags:
Regeneron, dupilumab, Anacor, Crisaborole Topical Ointment, psoriasis, eczema
Regeneron Pharmaceuticals Inc Jumps on Positive Clinical Data
Motley Fool
Sat, 04/2/16 - 02:00 pm
Tags:
Regeneron, clinical trials, dupilumab, eczema, atopic dermatitis
Regeneron's Eczema Data Look Great. Don't Believe Me? Ask A Patient
Forbes
Fri, 04/1/16 - 10:14 am
Tags:
Regeneron, eczema, dupilumab
Biogen's Newer Problems; Their Relevance To The Biotech Sector
Seeking Alpha
Mon, 03/28/16 - 09:22 pm
Tags:
Biogen, Tecfidera, Merck, Ionis Pharmaceuticals, Gilead Sciences, Amgen, Regeneron
Patent Troubles Hit Biogen After Gilead, Regeneron; What’s Next?
Bidness, ETC
Fri, 03/25/16 - 09:39 am
Tags:
Biogen, Gilead, Regeneron, patents, Tecfidera, Harvoni, Sovaldi
Regeneron and Bayer To Jointly Develop Novel Combination Therapy for Eye Diseases
Yahoo
Thu, 03/24/16 - 09:56 am
Tags:
Bayer, Regeneron, eye disease, nesvacumab, Aflibercept
Why one analyst thinks a Sanofi and Regeneron cholesterol drug will be yanked
Stat
Wed, 03/23/16 - 09:36 pm
Tags:
Sanofi, Regeneron, Praluent, PCKS9 inhibitors
Gilead, Biogen Troubles Remind Investors Why Strong Drug Patents Are Vital
TheStreet.com
Wed, 03/23/16 - 09:24 pm
Tags:
Gilead Sciences, Biogen, patents, Merck, Kyle Bass, Amgen, Regeneron, Sanofi
Amgen's PCSK9 patent win 'reasonably likely' to push Sanofi's Praluent off the market: Analyst
Fierce Pharma
Tue, 03/22/16 - 04:12 pm
Tags:
Amgen, patents, Sanofi, PCSK9 inhibitors, Regeneron, Repatha, Praluent
3 Biotech Stocks to Buy in March
Motley Fool
Sat, 03/19/16 - 01:55 pm
Tags:
biotech, Portola Pharmaceuticals, Regeneron, Ionis Pharmaceuticals
Regeneron, Sanofi Strongly Disagree to Jury’s Verdict in Amgen Patent Trial
Bidness, ETC
Wed, 03/16/16 - 07:22 pm
Tags:
Sanofi, Regeneron, Amgen, patents, PCSK9, Repatha, Praluent
Should AbbVie Fear Sanofi-Regeneron Drug Trial Data?
Bidness, ETC
Sat, 03/12/16 - 09:41 am
Tags:
AbbVie, Sanofi, Regeneron, clinical trials, Sarilumab, Humira, biosimilars, rheumatoid arthritis
Regeneron Eye Drug's Advantage Over Roche's Narrowed in Trial
Bloomberg
Sun, 02/28/16 - 10:52 am
Tags:
Regeneron, dry eye disease, Roche, Lucentis, Eylea
Amgen Ahead of Regeneron; Controlling 60% of PCSK-9 Market
Bidness, ETC
Wed, 02/17/16 - 10:46 am
Tags:
Amgen, Regeneron, Sanofi, PCSK9 inhibitors, Repatha, Praluent
Why Regeneron Pharmaceuticals’ SG&A Expenses Jumped in 2015
Yahoo/Market Realist
Wed, 02/17/16 - 10:37 am
Tags:
Regeneron, earnings
Express Scripts sees slow 2016 sales for new cholesterol drugs
Yahoo/Reuters
Fri, 02/12/16 - 04:15 pm
Tags:
Express Scripts, PCSK9 inhibitors, Amgen, Regeneron, Sanofi, Repatha, Praluent
Big Pharma's new PCSK9, heart failure meds stuck in the slow lane. What gives?
Fierce Pharma Marketing
Wed, 02/10/16 - 03:20 pm
Tags:
PCSK9 inhibitors, heart failure, Praluent, Repatha, Novartis, Amgen, Sanofi, Regeneron
Amgen Is Now Strides Ahead of Regeneron in the PCSK9 Race
Bidness, ETC
Tue, 02/9/16 - 04:23 pm
Tags:
Amgen, Regeneron, PCSK9 inhibitors, Praluent, Repatha
Regeneron misses Street 4Q forecasts
Yahoo/AP
Tue, 02/9/16 - 09:05 am
Tags:
Regeneron, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.